Skip to main content
. 2023 Oct 18;21:381. doi: 10.1186/s12951-023-02147-z

Table 1.

LNPs for the delivery of siRNA

LNPs Shape Type of study Aid Ref.
DOPE, DOTMA, DPPE-PEG 2000 Spherical In-vivo Receptor-mediated targeted delivery [108]
Toc-siRNA Spherical In-vivo Improved stability and cleaving efficiency of siRNA, targeted delivery, no side effects [109]
DLinDAP, DLinDMA, DLinKDMA, or DLinKC2-DMA Spherical In-vitro [110]
AtuFECT01 Spherical In-vivo and In-vitro Targeted delivery, stable in bloodstream [111]